The accumulation of exosome-associated microRNA-1246 and microRNA-150-3p in human red blood cell suspensions.
Exosome
MicroRNA
Red blood cell (RBC) suspensions
Transfusion-related immunomodulation (TRIM)
Journal
Journal of translational medicine
ISSN: 1479-5876
Titre abrégé: J Transl Med
Pays: England
ID NLM: 101190741
Informations de publication
Date de publication:
27 05 2021
27 05 2021
Historique:
received:
08
01
2021
accepted:
17
05
2021
entrez:
28
5
2021
pubmed:
29
5
2021
medline:
1
7
2021
Statut:
epublish
Résumé
Transfusion-related immunomodulation (TRIM) can be caused by exosomes, in which case, microRNAs (miRNAs) are one critical factor impacting exosome behavior. This study aims to investigate and analyze the expression profiles of exosomal miRNA in red blood cell (RBC) suspensions during storage and to identify potential TRIM-related miRNAs as well as their potential functions. A total of 25 packs of RBC suspensions were randomly collected. Exosome were extracted by ultracentrifugation and then identified and characterized by nanoparticle tracking analysis (NTA), transmission electron microscopy (TEM) and western blot (WB). Exosomal miRNA profiles were acquired using gene chips in five packs on week 1 and week 5. The expression data were compared from the two time points identifying accumulated miRNAs with statistical significance and their predicted targeting genes were analyzed. Based on the gene chip results, quantitative reverse transcription-polymerase chain reactions (qRT-PCR) were performed to verify miRNA accumulation in the rest 20 packs sampling on week 1, 3 and 5. Gene chip analysis revealed that most exosomal miRNAs were enriched as the storage period progressed. Compared to samples from week 1, week 5 samples exhibited a total of 539 differential miRNA expressions, among which, 159 were statistically significant (P < 0.05) and 148 (93.08%) were accumulated. In the bioinformatics functional analysis, significant immunoregulatory annotations related to the thyroid hormone, mitogen-activated protein kinase (MAPK), focal adhesion and RAS signaling pathways were identified. The top 17 differential expression miRNAs were validated by qRT-PCR. The results confirmed that all the 17 miRNAs were accumulated with increasing storage time. In particular, miRNA-1246 and miRNA-150-3p were the most enriched strands by more than 150-folds in the 5-week storage period. As storage progressed, numerous exosomal miRNAs accumulated in the RBC suspensions, which are informatically connected to multiple immuno-signaling pathways. MiRNA-1246 and miRNA-150-3p may be essential mediators impacting the immunoregulation functions of exosomes in RBC suspensions, considering their significant accumulating scales. Further research should therefore focus on the relationship between these miRNAs and TRIM.
Sections du résumé
BACKGROUND
Transfusion-related immunomodulation (TRIM) can be caused by exosomes, in which case, microRNAs (miRNAs) are one critical factor impacting exosome behavior. This study aims to investigate and analyze the expression profiles of exosomal miRNA in red blood cell (RBC) suspensions during storage and to identify potential TRIM-related miRNAs as well as their potential functions.
METHODS
A total of 25 packs of RBC suspensions were randomly collected. Exosome were extracted by ultracentrifugation and then identified and characterized by nanoparticle tracking analysis (NTA), transmission electron microscopy (TEM) and western blot (WB). Exosomal miRNA profiles were acquired using gene chips in five packs on week 1 and week 5. The expression data were compared from the two time points identifying accumulated miRNAs with statistical significance and their predicted targeting genes were analyzed. Based on the gene chip results, quantitative reverse transcription-polymerase chain reactions (qRT-PCR) were performed to verify miRNA accumulation in the rest 20 packs sampling on week 1, 3 and 5.
RESULTS
Gene chip analysis revealed that most exosomal miRNAs were enriched as the storage period progressed. Compared to samples from week 1, week 5 samples exhibited a total of 539 differential miRNA expressions, among which, 159 were statistically significant (P < 0.05) and 148 (93.08%) were accumulated. In the bioinformatics functional analysis, significant immunoregulatory annotations related to the thyroid hormone, mitogen-activated protein kinase (MAPK), focal adhesion and RAS signaling pathways were identified. The top 17 differential expression miRNAs were validated by qRT-PCR. The results confirmed that all the 17 miRNAs were accumulated with increasing storage time. In particular, miRNA-1246 and miRNA-150-3p were the most enriched strands by more than 150-folds in the 5-week storage period.
CONCLUSIONS
As storage progressed, numerous exosomal miRNAs accumulated in the RBC suspensions, which are informatically connected to multiple immuno-signaling pathways. MiRNA-1246 and miRNA-150-3p may be essential mediators impacting the immunoregulation functions of exosomes in RBC suspensions, considering their significant accumulating scales. Further research should therefore focus on the relationship between these miRNAs and TRIM.
Identifiants
pubmed: 34044888
doi: 10.1186/s12967-021-02887-2
pii: 10.1186/s12967-021-02887-2
pmc: PMC8157439
doi:
Substances chimiques
MIRN1246 microRNA, human
0
MIRN150 microRNA, human
0
MicroRNAs
0
Suspensions
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
225Références
Blood Transfus. 2019 Jan;17(1):27-52
pubmed: 30653459
Transfus Apher Sci. 2016 Dec;55(3):281-291
pubmed: 27865649
Crit Care. 2009;13(5):R151
pubmed: 19772604
Sci Rep. 2020 Aug 3;10(1):13045
pubmed: 32747644
Crit Care Med. 2006 May;34(5 Suppl):S151-9
pubmed: 16617260
J Am Coll Surg. 2012 Apr;214(4):648-55; discussion 656-7
pubmed: 22342784
Transfus Apher Sci. 2015 Oct;53(2):137-45
pubmed: 26596959
Vox Sang. 2006 Jul;91(1):13-9
pubmed: 16756596
Immunol Lett. 2017 Apr;184:76-83
pubmed: 28216261
Exp Ther Med. 2020 Mar;19(3):1997-2007
pubmed: 32104259
Blood Transfus. 2017 May;15(3):222-231
pubmed: 28518049
Blood Transfus. 2012 Jul;10(3):290-5
pubmed: 22395349
J BUON. 2018 May-Jun;23(3):672-677
pubmed: 30003736
Annu Rev Pathol. 2015;10:83-110
pubmed: 25621658
Oncogene. 2020 Jan;39(2):428-442
pubmed: 31485019
Int J Mol Sci. 2016 Dec 02;17(12):
pubmed: 27918449
Biomed Res Int. 2019 Jun 13;2019:2045915
pubmed: 31312654
Nat Rev Cancer. 2003 Jan;3(1):11-22
pubmed: 12509763
Semin Cancer Biol. 2019 Feb;54:131-137
pubmed: 30769101
Hematology. 2005;10 Suppl 1:208-14
pubmed: 16188675
Blood. 2015 May 14;125(20):3202-12
pubmed: 25838349
Transplant Proc. 1973 Mar;5(1):253-9
pubmed: 4572098
BMC Genomics. 2015 Nov 16;16:952
pubmed: 26573221
Blood Transfus. 2010 Jun;8 Suppl 3:s26-30
pubmed: 20606746
Am J Transl Res. 2017 Mar 15;9(3):1287-1296
pubmed: 28386354
Thromb Res. 2020 Dec;196:543-549
pubmed: 33142231
Cold Spring Harb Perspect Biol. 2012 Mar 01;4(3):
pubmed: 22296764
Cell. 2009 Jan 23;136(2):215-33
pubmed: 19167326
Blood. 2014 Jan 30;123(5):687-96
pubmed: 24335232
Oncotarget. 2018 Oct 5;9(78):34838-34854
pubmed: 30410681
FEBS J. 2017 Oct;284(20):3355-3361
pubmed: 28796323
Genomics Proteomics Bioinformatics. 2015 Feb;13(1):17-24
pubmed: 25724326
Dev Cell. 2019 May 6;49(3):347-360
pubmed: 31063754
Transfusion. 2018 Mar;58(3):804-815
pubmed: 29383722
J Biol Chem. 2017 Apr 7;292(14):6004-6013
pubmed: 27974462
Oxid Med Cell Longev. 2017;2017:5189138
pubmed: 28811864